Skip to content
healthcare.dev

carisoprodol

NDC 76420-852, carisoprodol, tablet, from Asclemed USA, Inc..

Product NDC
76420-852
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040792
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARISOPRODOL250 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
76420-852-0176420085201100 TABLET in 1 BOTTLE (76420-852-01)
76420-852-307642008523030 TABLET in 1 BOTTLE (76420-852-30)
76420-852-607642008526060 TABLET in 1 BOTTLE (76420-852-60)
76420-852-907642008529090 TABLET in 1 BOTTLE (76420-852-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/301f5e6a-54e1-4885-b9cb-de475de59b22

Use it

Look up 76420-852 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-852. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.